Multi-omics study maps cervical cancer molecular landscape in Chinese patients

PLOS Biology reported that researchers analysed multi-omics profiles from 112 Chinese cervical cancer patient samples. The study aimed to clarify the molecular basis of disease heterogeneity in Asian populations, where the molecular profile has remained poorly understood despite cervical cancer being a major cause of mortality among women. [1]

Multiomics is an analytical approach that combines multiple biological datasets, such as the genome, epigenome, transcriptome, proteome, metabolome, exposome, and microbiome. Integrating these diverse datasets allows researchers to identify novel associations, pinpoint biomarkers, and clarify complex biological relationships in disease and physiology. [2]

According to PLOS Biology, genomic and transcriptomic sequencing can guide precision diagnosis in cervical cancer. By examining multi-omics profiles across the patient samples, the study identified key molecular pathways and biomarkers that can help guide therapeutic strategies. [1]